CV Lattes
ORCID
Abstract
The use of chimeric antigen receptor (CAR) modified T lymphocyte immunotherapy has been shown to be effective in the treatment of chemotherapy and / or relapse resistant leukemias and lymphomas. Currently, lentiviral vectors are considered the most used gene modification vehicle of this therapy, offering significant advantages. Thus, with the growing interest in these vectors and the high…